✦ LIBER ✦

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

✍ Scribed by E Tauber; H Kollaritsch; M Korinek; P Rendi-Wagner; B Jilma; C Firbas; S Schranz; E Jong; A Klingler; S Dewasthaly; CS Klade

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-clinical and phase I clinical trials

✍ Syoji Kuzuhara; Hideki Nakamura; Kenshi Hayashida; Junko Obata; Motoharu Abe; Ke 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Efficacy, safety, and immunogenicity of

✍ P Noel Barrett; Gregory Berezuk; Sandor Fritsch; Gerald Aichinger; Mary Kate Har 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 209 KB

Safety and immunogenicity of an inactiva

✍ Gerald Aichinger; Hartmut J. Ehrlich; John G. Aaskov; Sandor Fritsch; Christiane 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Safety and immunogenicity of a freeze-dr

✍ Kenji Okada; Toshiaki Iwasa; Junko Namazue; Masateru Akechi; Shigeharu Ueda 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Safety and immunogenicity of an inactiva

✍ Jiangtao Lin; Jiansan Zhang; Xiaoping Dong; Hanhua Fang; Jiangting Chen; Nan Su; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 135 KB

Immunogenicity, safety and tolerability

✍ Joseph Torresi; Karen McCarthy; Emmanuel Feroldi; Claude Méric 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 319 KB